SleepCogni has secured £300k in a bridging round to support international expansion and regulatory approvals.
The bridging round extends the company runway ahead of a larger raise planned for 2025.
SleepCogni is a medical technology company based in Sheffield that develops digital solutions for insomnia care. The firm combines clinical insights with advanced monitoring to improve patient outcomes.
Sheffield based medical technology firm SleepCogni has secured £300k in a bridging round to extend its operational runway ahead of a larger funding raise planned for 2025. The capital will support regulatory approvals and commercial expansion into the global sleep technology market, drawing on backing from existing investors and grants.
The company has also strengthened its leadership team alongside the raise. Long-term backer Mark Milton-Edwards has invested in the round and joined the firm as a non-executive director, while Joseph Hawkins has been promoted to chief operating officer.
From the founder
"I am delighted to strengthen our commercial team and announce this additional funding. The continued support from our investors is a testament to their confidence in our mission and the team’s ability to deliver. With a well-rounded executive team featuring experience from global leaders in pharmaceuticals like Teva, healthcare insurance giants such as Aetna, and consumer retail leaders like Apple, we are well-positioned to drive the business forward."
Richard Mills
CEO at SleepCogni
Use of funds
- 01Expand into international markets
Categories
About the company
SleepCogni
SleepCogni builds digital technology to transform insomnia care and sleep health.